We are live on ! Find out more
ATHE

Alterity Therapeutics
ATHE

18 hedge funds and large institutions have $1M invested in Alterity Therapeutics in 2025 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

13% more funds holding

Funds holding: 16 → 18 (+2)

0.39% less ownership

Funds ownership: 2.18% → 1.79% (-0.39%)

21% less capital invested

Capital invested by funds: $1.26M → $1M (-$258K)

80% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 5

Holders
18
Holders Change
+2
Holders Change %
+12.5%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
5
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RhumbLine Advisers
RhumbLine Advisers
Massachusetts
+$4.74K
2
GI
GAMMA Investing
California
+$3.02K
3
MI
Motiv8 Investments
Florida
+$153
4
CA
CoreCap Advisors
Michigan
+$80
5
TRCT
Tower Research Capital (TRC)
New York
+$38

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$20.4K
2
Morgan Stanley
Morgan Stanley
New York
-$19.1K
3
Citigroup
Citigroup
New York
-$2.43K
4
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$1.53K
5
EWA
EverSource Wealth Advisors
Alabama
-$666
Name Holding Trade Value Shares
Change 		Change in
Stake
TLCM
1
Twin Lakes Capital Management
California
$429K – – –
Morgan Stanley
2
Morgan Stanley
New York
$196K -$19.1K -5,000 -7%
HWM
3
HB Wealth Management
Georgia
$180K – – –
GT
4
Greenleaf Trust
Michigan
$98.6K – – –
Citadel Advisors
5
Citadel Advisors
Florida
$51.8K -$20.4K -5,333 -24%
BNP Paribas Financial Markets
6
BNP Paribas Financial Markets
France
$21.3K -$1.53K -400 -5%
Acadian Asset Management
7
Acadian Asset Management
Massachusetts
$14K – – –
RhumbLine Advisers
8
RhumbLine Advisers
Massachusetts
$6.55K +$4.74K +1,241 +140%
GI
9
GAMMA Investing
California
$2.43K +$3.02K +790 New
Osaic Holdings
10
Osaic Holdings
Arizona
$247 -$382 -100 -55%
BTI
11
Blue Trust Inc
Georgia
$123 – – –
FFA
12
Farther Finance Advisors
California
$68 – – –
CA
13
CoreCap Advisors
Michigan
$65 +$80 +21 New
TRCT
14
Tower Research Capital (TRC)
New York
$31 +$38 +10 New
SPIA
15
Steward Partners Investment Advisory
New York
$18 – – –
Citigroup
16
Citigroup
New York
$3 -$2.43K -635 -100%
DB
17
Danske Bank
Denmark
$3 – – –
EWA
18
EverSource Wealth Advisors
Alabama
– -$666 -177 Closed
SS
19
SBI Securities
Japan
– -$4 -1 Closed
MI
20
Motiv8 Investments
Florida
– +$153 +40 New

ATHE Hedge Fund Activity: Q4 2025 in Review

18 of the 8,225 institutional investors tracked by Wall St. Rank reported a position in Alterity Therapeutics (ATHE) for Q4 2025, worth a combined $1M — down 21% from $1.26M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new ATHE positions and 2 closed out — a net gain of 2 holders — while 1 added to existing stakes and 5 trimmed.

The largest buyer was RhumbLine Advisers, adding an estimated $4.74K. The largest seller was Citadel Advisors, cutting an estimated $20.4K.

  • 18 institutional investors held Alterity Therapeutics (ATHE) as of Q4 2025, up from 16 in Q3 2025.
  • Funds reported $1M of Alterity Therapeutics stock for Q4 2025, down 21% quarter-over-quarter.
  • 4 funds opened new Alterity Therapeutics positions in Q4 2025 and 2 closed out, a net change of +2 holders.
  • The largest Alterity Therapeutics buyer in Q4 2025 was RhumbLine Advisers, an estimated $4.74K added.
  • The largest Alterity Therapeutics seller in Q4 2025 was Citadel Advisors, an estimated $20.4K sold.

Based on aggregated 13F filings for Q4 2025.